Description
- Appetite‑weight regulation: dual GLP‑1R/GCGR co‑agonist suppresses food intake and elevates hepatic energy expenditure in obesity‑related pre‑clinical models.
- Glycemic homeostasis research: promotes glucose‑dependent insulin secretion for blood‑glucose control investigation.
- Hepatic‑lipid metabolism: enhances hepatic fatty‑acid oxidation for MASH and liver‑fibrosis‑related mechanism study.
- Metabolic‑syndrome study: explored for insulin‑resistance improvement and lipid‑profile modulation in metabolic‑disorder models.
